Cutaneous leishmaniasis: current and future management

Expert Rev Anti Infect Ther. 2003 Dec;1(4):563-70. doi: 10.1586/14787210.1.4.563.

Abstract

Leishmaniasis remains a major world health problem that continues to increase in incidence. This review considers epidemiology, clinical features, diagnosis and current treatment options. Recent developments in the treatment of simple cutaneous leishmaniasis are discussed followed by speculation about future therapies.

Publication types

  • Review

MeSH terms

  • Amphotericin B / therapeutic use
  • Animals
  • Antimony Sodium Gluconate / therapeutic use
  • Humans
  • Immunotherapy
  • Leishmania / physiology
  • Leishmaniasis, Cutaneous / diagnosis
  • Leishmaniasis, Cutaneous / drug therapy*
  • Paromomycin / therapeutic use
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use

Substances

  • Phosphorylcholine
  • miltefosine
  • Paromomycin
  • Amphotericin B
  • Antimony Sodium Gluconate